Floaters, Vitreous Opacities
Conditions
Brief summary
The goal of this clinical trial is to capture imaging data of eye floaters in the population to build an imaging database to learn more about them in. Participants will imaged with an investigational ophthalmic imaging device to capture images of their floaters.
Interventions
DEVICESVO-ID
Combined scanning laser ophthalmoscope (SLO) and optical coherence tomography (OCT) for imaging of the eye
Sponsors
PulseMedica
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Aged 18 years or older * Symptomatic vitreous opacities (floaters) in vision * Clear ocular media, to allow a clear view of the vitreous for the SVO-ID
Exclusion criteria
* Younger than 18 years of age * Presence of vitreous hemorrhage * Cataract Grade 3 and above * Opacification of lens, cornea, or vitreous * Diagnosis of narrow angle glaucoma * Refractive error is outside the range of -6D to+3D * Astigmatism is outside the range of +/-2D of cylinder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Successful capture of SLO and OCT imaging data of SVOs for algorithm development | Through study completion, an average of 6-8 months | Successful collection of SLO and OCT imaging data |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Collection of patient-reported symptoms | Through study completion, an average of 6-8 months | Patient feedback regarding symptoms related to SVOs being imaged |
Countries
Canada
Outcome results
None listed